Related Experiment Video
Updated: Aug 7, 2026
Assessment and Evaluation of the High Risk Neonate: The NICU Network Neurobehavioral Scale
Published on: August 25, 2014
Newborn screening: toward a uniform screening panel and system
Insights
A standardized panel of 29 mandated conditions and 25 additional conditions for newborn screening programs was recommended. This aims to improve consistency in newborn screening outcomes and data evaluation across states.
Area of Science:
- Medical Genetics
- Public Health
- Pediatrics
Background:
- State newborn screening programs require standardized outcomes and guidelines for consistent care.
- The Maternal and Child Health Bureau and American College of Medical Genetics collaborated to address this need.
- Evaluating outcome data and defining responsibilities are crucial for effective screening.
Framework:
- An expert panel recommended a uniform panel of conditions for state newborn screening.
- The process involved identifying core conditions and those with clinical significance.
- Standardization aims to improve the efficacy and consistency of newborn screening.
Implementation:
- 29 conditions were identified for mandated newborn screening.
- An additional 25 conditions were included for differential diagnosis or clinical significance.
- The report details the identification process and provides recommendations for implementation.
Implications:
- Standardized newborn screening can lead to earlier diagnosis and intervention.
- Consistent guidelines improve the evaluation of screening program effectiveness.
- This framework supports enhanced public health outcomes for infants and children.
Abstract:
The Maternal and Child Health Bureau commissioned the American College of Medical Genetics to outline a process for the standardization of outcomes and guidelines for state newborn screening programs and to define responsibilities for collecting and evaluating outcome data, including a recommended uniform panel of conditions to include in state newborn screening programs. The expert panel identified 29 conditions for which screening should be mandated. An additional 25 conditions were identified because they are part of the differential diagnosis of a condition in the core panel, they are clinically significant and revealed with screening technology but lack an efficacious treatment, or they represent incidental findings for which there is potential clinical significance. The process of identification is described, and recommendations are provided.
